Therapies Archives - Oncology Central Oncology Central

Must read

23 May 2019 Opinion
ASCO 2019: what should you look out for?

9 May 2019 Brain and neurologic
Novel drug could be world’s first treatment for a pediatric brain cancer
1 May 2019 Breast
ESMO Breast Cancer 2019: should HER2-positive breast cancer treatment de-escalation be personalized?
30 Apr 2019 Breast
ESMO Breast Cancer 2019: good outcomes in young women with aggressive breast cancer
5 Apr 2019 Lung
Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung
5 Apr 2019 Hematologic
Hematological malignancy stem cell transplants: improving matches to reduce mortality
1 Apr 2019 Hematologic
AACR19: umbralisib trial results give support for use as a marginal zone lymphoma drug

Must watch

14 Nov 2018 Pancreatic
Emerging treatment options for pancreatic cancer with Thomas Seufferlein

Stay up to date

Upcoming event

ESMO Breast Cancer 2019 – annual congress

May 2, 2019 – May 4, 2019

Berlin, Germany

View all

Upcoming event

American Society of Clinical Oncology (ASCO) annual meeting

May 31, 2019 – June 4, 2019

IL, USA

View all

Tweets

Oncology Central @OncologyCentral·

#ASCO19 . Data has highlighted that insurance type and regional income are two key factors that impact the longevity for #multiplemyeloma patients. Click the image below for the full news story: https://t.co/EIwAar7VkK

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

ASCO 2019: what should you look out for?

Novel drug could be world’s first treatment for a pediatric brain cancer

ESMO Breast Cancer 2019: should HER2-positive breast cancer treatment de-escalation be personalized?

ESMO Breast Cancer 2019: good outcomes in young women with aggressive breast cancer

Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

Hematological malignancy stem cell transplants: improving matches to reduce mortality

AACR19: umbralisib trial results give support for use as a marginal zone lymphoma drug

Emerging treatment options for pancreatic cancer with Thomas Seufferlein

AACR19: HER2 targeted CAR-T cell therapy shows promise in advanced sarcomas patients

AACR19: mesothelin targeted CAR-T cell therapy – a possible treatment for solid tumors

Defining aggressive or early progressing non-oncogene-addicted non-small-cell lung cancer: a separate disease entity?

Pembrolizumab could effectively treat recurrent glioblastoma, study suggests

Palbociclib halts tumor growth in early breast cancer patients

Dual-action virus targets both cancer cells and associated fibroblasts

Promising Phase I trial for anti-HER2 antibody

NCRI 2018: Prostate cancer patients may prioritize the avoidance of side-effects over survival probability

What are the top 5 breast cancer advancements of 2018?

A dog’s 3D printed implant shows potential for cancer surgeries

Zika vaccine yields promising results for treating glioblastoma

New tool could predict how cancer will resist drugs before they are given to patients

Capturing Cancer: Oncology Central Photography Competition

Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

Comprehensive CAR T-cell therapy pediatric guidelines developed

ASCO18: Day 3 update

Login

Therapies

Must read

ASCO 2019: what should you look out for?

Novel drug could be world’s first treatment for a pediatric brain cancer

ESMO Breast Cancer 2019: should HER2-positive breast cancer treatment de-escalation be personalized?

ESMO Breast Cancer 2019: good outcomes in young women with aggressive breast cancer

Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

Hematological malignancy stem cell transplants: improving matches to reduce mortality

AACR19: umbralisib trial results give support for use as a marginal zone lymphoma drug

Must watch

Emerging treatment options for pancreatic cancer with Thomas Seufferlein

AACR19: HER2 targeted CAR-T cell therapy shows promise in advanced sarcomas patients

AACR19: mesothelin targeted CAR-T cell therapy – a possible treatment for solid tumors

Defining aggressive or early progressing non-oncogene-addicted non-small-cell lung cancer: a separate disease entity?

Pembrolizumab could effectively treat recurrent glioblastoma, study suggests

Palbociclib halts tumor growth in early breast cancer patients

Dual-action virus targets both cancer cells and associated fibroblasts

Promising Phase I trial for anti-HER2 antibody

NCRI 2018: Prostate cancer patients may prioritize the avoidance of side-effects over survival probability

What are the top 5 breast cancer advancements of 2018?

A dog’s 3D printed implant shows potential for cancer surgeries

Zika vaccine yields promising results for treating glioblastoma

New tool could predict how cancer will resist drugs before they are given to patients

Capturing Cancer: Oncology Central Photography Competition

Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

Comprehensive CAR T-cell therapy pediatric guidelines developed

ASCO18: Day 3 update

Stay up to date

Oncology Central Newsletter